• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Leerink Partners

Leerink fund raises $313m for HIT plays

September 29, 2017 By Brad Perriello

A fund backed by investment bank Leerink Partners raised $313 million for investments in the health information technology sector. Boston-based Leerink Transformation Partners said its first fund was significantly oversubscribed compared with the $250 million it initially sought to raise. Co-founder Todd Cozzens is a medical device industry veteran and former Sequoia Capital partner; Dr. Jared […]

Filed Under: Funding Roundup, Health Information Technology, Wall Street Beat Tagged With: Leerink Partners, Venture Capital/Private Equity

Leerink Partners upgrade sends Baxter shares up

April 4, 2017 By Brad Perriello

Baxter (NYSE:BAX) shares gained today after analysts at Leerink Partners upgraded their view of the stock, citing its strong free cash flow and a string of “beat-‘n’raise” quarters from the Chicago-area healthcare giant. Leerink analysts Danielle Antalffy and Rebecca Wang boosted their rating on BAX shares from “market perform” to “outperform” and boosted the price target to […]

Filed Under: Wall Street Beat Tagged With: Baxter, Leerink Partners

Analyst: Insulet’s drug-delivery biz a long-term growth driver

October 3, 2016 By Sarah Faulkner

Insulet’s (NSDQ:PODD) drug-delivery business will be a long-term growth driver for the company by as much as 20% a year for the next few years, according to Leerink Partners analysts. Billerica, Mass.-based Insulet generates 86% of its revenue from its OmniPod insulin delivery device, according to Leerink. The OmniPod technology could be easily adapted to […]

Filed Under: Business/Financial News, Drug-Device Combinations Tagged With: Amgen, Insulet, Leerink Partners

EuroPCR 2016 Update: TAVR innovations, FFR systems in the spotlight

May 18, 2016 By Fink Densford

UPDATED May 20, 2016, with more results out of Paris. St. Jude Medical (NYSE:STJ) announced it won CE Mark approval in the European Union for its PressureWire X Guidewire fractional flow reserve measurement system and is launching the product in Europe. The company announced the launch and clearance at the EuroPCR meeting in Paris this week. […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Drug-Eluting Stents, Replacement Heart Valves, Stent Grafts, Stents Tagged With: Biotronik, Edwards Lifesciences, EuroPCR 2016, InspireMD, Leerink Partners, Medinol Ltd, Reva Medical Inc., stjudemedical

Neovasc squeaks by Q2, positive on Tiara trial

August 6, 2015 By Fink Densford

Neovasc (NASDAQ:NVCN) reported 2nd quarter sales ahead of estimates, though down from 2014 and marked by growing losses, but rallied around the progress of its Tiara transcatheter mitral valve implant feasibility trial. The company’s 30-patient Tiara 1 trial has 2 study patients implanted, in addition to 5 patients implanted through compassionate use regulations. Of the 3 compassionate […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Catheters, MassDevice Earnings Roundup Tagged With: Leerink Partners, neovasc

Docs doubt ‘repless’ sales model for medical devices

March 18, 2015 By Brad Perriello Leave a Comment

Docs doubt 'repless' sales model for medical devices

A pair of high-volume orthopedists who specialize in hip and knee replacement surgeries are skeptical of generic or "repless" sales models, in which medical device companies offer lower-cost implants without a sales rep on hand to advise during the procedure.

Filed Under: News Well, Orthopedics Tagged With: Leerink Partners, Royal Oak Medical Devices, Sales, Smith & Nephew, Stryker, wrightmedical

Analyst says BSX may take CRM lead | Medtech Wall Street news for the week of September 29, 2014

October 2, 2014 By MassDevice Leave a Comment

Analyst: Boston Scientific could take CRM lead

September 25, 2014 by Alexander Soule

Filed Under: Food & Drug Administration (FDA), News Well, Wall Street Beat Tagged With: Alimera Sciences, Boston Scientific, Echo Therapeutics Inc., Engaged Capital, Leerink Partners, Orthofix, pSivida Corp., stjudemedical, Volcano Corp.

Analyst: Boston Scientific could take CRM lead

September 25, 2014 By Alex Soule Leave a Comment

Analyst: Boston Scientific could take pacer lead

Filed Under: News Well, Wall Street Beat Tagged With: Boston Scientific, Cardiac Rhythm Management, Leerink Partners, stjudemedical

Analyst: Inogen’s poised for big things with newly cleared at-home oxygen system

June 24, 2014 By Arezu Sarvestani Leave a Comment

Wall Street has big expectations for Inogen's newly cleared home oxygen system

Wall Street is looking for Inogen (NSDQ:INGN) to make a big splash with its new Inogen At Home oxygen concentration system, which won FDA clearance today.

Filed Under: News Well, Regulatory/Compliance, Respiratory Tagged With: Inogen, Leerink Partners

HRS2014: Perforations, deaths temporarily derail St. Jude’s E.U. Nanostim study

May 12, 2014 By Arezu Sarvestani Leave a Comment

Updated May 12, 2014, at 5:30 p.m. with confirmation from St. Jude Medical.

Filed Under: Cardiac Implants, News Well Tagged With: Cardiac Rhythm Management, Clinical Trials, Heart Rhythm Society, HRS 2014, Leerink Partners, stjudemedical

Medtech outlook 2013: Major environmental factors for the year ahead

January 4, 2013 By MassDevice staff Leave a Comment

rising and falling illustration

Wall Street analysts released their predictions for the major medical device industry trends of 2013, and the outlook isn’t much to celebrate.

Filed Under: News Well, Wall Street Beat Tagged With: Leerink Partners

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS